Theragen Etex Co., Ltd. logo

Theragen Etex Co., Ltd. (066700)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,205. 00
-60
-2.649%
89.78B Market Cap
- P/E Ratio
- Div Yield
52,348 Volume
- Eps
2,265
Previous Close
Add Transaction
Day Range
2,205 2,285
Year Range
1,845 3,470
Want to track 066700 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

066700 closed today lower at ₩2,205, a decrease of -2.649% from yesterday's close, completing a monthly increase of 5.7554% or ₩120. Over the past 12 months, 066700 stock lost -31.9444%.
066700 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

066700 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Theragen Etex Co., Ltd. (066700) FAQ

What is the stock price today?

The current price is ₩2,205.00.

On which exchange is it traded?

Theragen Etex Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 066700.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 89.78B.

Has Theragen Etex Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Theragen Etex Co., Ltd. Profile

Health Care Technology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Theragen Etex Co., Ltd. stands as a significant entity within the healthcare and pharmaceutical sectors, specializing in the field of biopharmaceuticals. By harnessing the power of innovative technology, the company has established itself as a leader in genetic research and personalized medicine. It places a strong emphasis on genomics, making strides in the understanding and application of genetic data to enhance diagnostic and therapeutic processes. While its primary focus lies in serving the healthcare industry, Theragen Etex has also made inroads into dental materials, thereby broadening its scope and influence in the medical field. The commitment of Theragen Etex to developing cutting-edge healthcare solutions significantly contributes to tackling complex health issues, positioning the company at the forefront of biotechnological advances. In an era where the demand for personalized healthcare is ever-increasing, the role Theragen Etex plays in delivering precision medicine solutions is vital for the future of biopharmaceutical endeavors.

Products and Services

  • Genomic Sequencing
  • Offering comprehensive DNA analysis and sequencing services, Theragen Etex enables the identification of genetic mutations and anomalies. This crucial service paves the way for personalized treatment plans by providing valuable insight into an individual’s genetic makeup, thereby facilitating the development of targeted therapies.

  • DNA Analysis
  • A critical aspect of Theragen Etex's offerings, DNA analysis forms the backbone of its genomics focus. Through meticulous examination of genetic material, the company aims to unlock the potential for enhanced diagnostics and the formulation of precision medicine, significantly impacting patient care methodologies.

  • Personalized Medicine Solutions
  • At the heart of Theragen Etex's mission is the provision of personalized medicine solutions. By utilizing genetic information, the company strives to create tailored treatment and prevention strategies for various diseases. This approach ensures more effective and efficient healthcare, moving away from the one-size-fits-all model.

  • Dental Materials
  • Expanding its expertise beyond biopharmaceuticals, Theragen Etex also engages in the development of advanced materials for dental applications. This diversification reflects the company’s ambition to innovate across different sectors of healthcare, contributing valuable solutions to the dental industry.

Contact Information

Address: -
Phone: -